The Missing Temporal Coordinate: A Framework for Biopsy Timestamping and Chrono-Biobanking in Precision Oncology and Longevity Medicine

Precision medicine increasingly relies on biospecimen analysis for diagnosis, prognostic assessment, treatment selection, and longitudinal monitoring. Established biobanking frameworks address collection methods, processing delays, fixation, and storage. Collection times may also be recorded, but documentation may be inconsistent, and timestamps may not be retained in research datasets or considered in subsequent analyses. Because several physiological processes vary across the day, sampling time may provide relevant context for interpreting selected molecular and cellular measurements. In oncology, circadian regulation influences immune cell distribution, endocrine signaling, metabolism, and gene expression. Sampling time may therefore contribute to variability in selected blood-based biomarkers and molecular profiles. However, the magnitude and clinical relevance of these effects differ across analytes, tissues, and clinical settings and remain insufficiently characterized for many routinely used biomarkers. Similar considerations apply to geroscience and longevity medicine, where some measurements arise from systems with daily variation. Whether this variability meaningfully affects specific epigenetic clocks, biological age estimators, or assessments of intervention response requires direct validation. This narrative review examines evidence relevant to the temporal context of biospecimen collection and proposes a practical framework for timestamping and chrono-biobanking. Proposed core metadata include the local collection date and time, the applicable time zone or UTC (Coordinated Universal Time) offset when available, specimen type, anatomical site, and clearly distinguished processing timestamps. Additional information on fasting, medications, treatment exposure, sleep, and chronotype may be recorded according to the clinical or research question. Comparable collection windows may be useful for serial sampling when feasible and scientifically justified. The proposed framework prioritizes systematic documentation within existing workflows. Integration with electronic health records, laboratory systems, and biobank databases could facilitate the capture and preservation of collection times without delaying necessary care. These data may support temporal stratification, sensitivity analyses, and statistical adjustment where study design and data permit. The framework's feasibility and its effect on biomarker interpretation require empirical evaluation. Preserving sampling-time information provides a foundation for investigating its relevance to biomarker reproducibility and interpretation in precision oncology and longevity research.